Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/83B stock hub

FRA/83B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/83Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.1B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/83B

In the news

Latest news · FRA/83B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.8

P25 n/aP50 n/aP75 n/a

Trailing P/E5.9

P25 n/aP50 n/aP75 n/a

ROE37.5

P25 n/aP50 n/aP75 n/a

ROIC65.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/83B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

CNY

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	DE
Employees	6,109
Employees Change	691%
Employees Change Percent	12.39
Enterprise value	EUR 4.4B
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 6.1B
Price	EUR 2.39
Price currency	EUR
Rev Per Employee	352,724x
Sic	2836
Symbol	fra/83B
Website	https://www.3sbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	17.05%
EV Earnings	4.26x
EV/EBIT	3.51x
EV/EBITDA	3.34x
EV/FCF	3.9x
EV/Sales	2.06x
FCF yield	18.61%
Forward P/E	16.76x
P/B ratio	1.63x
P/E ratio	5.86x
P/S ratio	2.81x
PE Ratio10 Y	10.31x
PE Ratio3 Y	11.03x
PE Ratio5 Y	10.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	59.26%
EBITDA Margin	62.13%
FCF margin	52.31%
Gross margin	92.38%
Gross Profit	EUR 2B
Gross Profit Growth	111.02%
Gross Profit Growth Q	213.36%
Gross Profit Growth3 Y	31.21%
Gross Profit Growth5 Y	20.98%
Net Income	EUR 1B
Net Income Growth	305.78%
Net Income Growth Q	612.13%
Net Income Growth3 Y	72.29%
Net Income Growth5 Y	34.47%
Pretax Margin	60.74%
Profit Margin	47.93%
Profit Per Employee	EUR 169,072
ROA	21.68
Roa5y	9.29
ROCE	32.94
ROE	37.53
Roe5y	16.95
ROIC	65.9
Roic5y	22.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.14%
Cagr1y	89.52%
Cagr3y	41.64%
Cagr5y	27.99%
Div CAGR3	32.68%
Div CAGR5	2.5%
EPS Growth	303.6
EPS Growth Q	611.7
EPS Growth3 Y	71.4
EPS Growth5 Y	35.11
FCF Growth	267.35%
FCF Growth Q	402.1%
FCF Growth3 Y	85.56%
FCF Growth5 Y	47.48%
OCF Growth	202.03%
OCF Growth Q	312.57%
OCF Growth10 Y	21.81%
OCF Growth3 Y	69.34%
OCF Growth5 Y	33.37%
Revenue Growth	94.29x
Revenue Growth Q	182.72x
Revenue Growth3 Y	28.08x
Revenue Growth5 Y	18.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.59
Assets	EUR 4.4B
Cash	EUR 2.4B
Current Assets	EUR 2.8B
Current Liabilities	EUR 550.6M
Debt	EUR 318.8M
Debt EBITDA	EUR 0.24
Debt Equity	EUR 0.09
Debt FCF	EUR 0.28
Equity	EUR 3.7B
Interest Coverage	137.3
Liabilities	EUR 708M
Long Term Assets	EUR 1.6B
Long Term Liabilities	EUR 157.4M
Net Cash	EUR 2.1B
Net Cash By Market Cap	EUR 34.11
Net Cash Growth	513.93%
Net Debt EBITDA	EUR -1.54
Net Debt Equity	EUR -0.56
Net Debt FCF	EUR -1.83
Tangible Book Value	EUR 2.6B
Tangible Book Value Per Share	EUR 1.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.13
Inventory Turnover	1.46
Net Working Capital	EUR 63.1M
Quick ratio	4.66
Working Capital	EUR 2.2B
Working Capital Turnover	EUR 0.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.04%
Dividend Growth	-7.04%
Dividend Growth Years	0%
Dividend per share	EUR 0.03
Dividend Years	4
Dividend Yield	1.12%
Ex Div Date	2025-07-21
Last Dividend	EUR 0.03
Payout Frequency	Annual
Payout Ratio	6.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	162.74%
1Y total return	89.44%
200-day SMA	2.93
3Y total return	184.2%
50-day SMA	2.42
50-day SMA vs 200-day SMA	50under200
5Y total return	243.4%
All Time High	3.88
All Time High Change	-38.48%
All Time High Date	2025-09-05
All Time Low	0.53
All Time Low Change	350.38%
All Time Low Date	2022-03-15
ATR	0.08
Ch YTD	-9.58
High	2.39
High52	3.88
High52 Date	2025-09-09
High52ch	-38.48%
Low	2.39
Low52	1.25
Low52 Date	2025-05-12
Low52ch	90.96%
Ma50ch	-1.32%
Price vs 200-day SMA	-18.48%
RSI	46.73
RSI Monthly	57.33
RSI Weekly	45.19
Sharpe ratio	1.07x
Sortino ratio	2.06
Total Return	1.17%
Tr YTD	-9.58
Tr1m	-13.55%
Tr1w	-1.2%
Tr3m	-2.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.3B
Operating Income Growth	343.3
Operating Income Growth Q	729.2
Operating Income Growth3 Y	60.35
Operating Income Growth5 Y	35.06
Operating margin	59.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,852,796,591%
Net Borrowing	-120,929,969.5
Shares Insiders	5.79%
Shares Institutions	44.73%
Shares Qo Q	1.67%
Shares Yo Y	-0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.1B
Average Volume	5x
Bv Per Share	1.32
CAPEX	EUR -50.3M
Ch10y	137.7
Ch1m	-13.55
Ch1w	-1.2
Ch1y	87.95
Ch3m	-2.17
Ch3y	166.7
Ch5y	212
Ch6m	-23.49
Change	-2.05%
Change From Open	0
Close	2.44
Days Gap	-2.05
Depreciation Amortization	63,336,058.3
Earnings Date	2026-08-21
EBIT	EUR 1.3B
EBITDA	EUR 1.3B
EPS	EUR 0.42
F Score	7
FCF	EUR 1.1B
FCF EV Yield	25.63x
Financing CF	286,681,485
Fiscal Year End	December
Founded	1,993
Goodwill	520,232,068.4
Graham Number	3.6572
Graham Upside	53.21
Income Tax	EUR 201.2M
Investing CF	-223,369,845
Is Primary Listing	0
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Lynch Fair Value	EUR 10.18
Lynch Upside	326.3
Ma150	2.78
Ma150ch	-13.98%
Ma20	2.47
Ma20ch	-3.28%
Net CF	1,221,895,310
Next Earnings Date	2026-08-21
Open	2.39
P FCF Ratio	5.37
P OCF Ratio	5.14
Payment Date	2025-08-15
Ppne	670,514,280.9
Price Date	2026-05-08
Price EBITDA	EUR 4.52
Ptbv Ratio	2.34
Relative Volume	20x
Revenue	2,154,790,899x
SBC By Revenue	1.26x
Share Based Comp	27,175,396
Tax By Revenue	9.34x
Tax Rate	15.37%
Tr6m	-23.49%
Z Score	7.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/83B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$0.03 annual per share

Payout ratio

+6.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+2.5%

0 consecutive years of growth

Total shareholder yield

+1.2%

Next ex-dividend date: 2025-07-21

Performance

FRA/83B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/83B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.7%

Share of float held by funds and institutions

Insider ownership

+5.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

FRA/83B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.7

Neutral momentum band

Price vs 200-day MA

-18.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/83B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/83B stock rating?

fra/83B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/83B analysis?

The full report lives at /stocks/fra/83B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/83B?

The latest report frames fra/83B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/83B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.